Anti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma

被引：1
|
作者：
Chow, Ariel [1 ]
Pang, Roberta [1 ]
Chu, Andrew [1 ]
Ng, Lui [1 ]
Poon, Ronnie [1 ]
机构：
[1] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-5382
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5382
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Anti-tumor Efficacy of a Recombinant Human Arginase in Human Hepatocellular Carcinoma
    Chow, Ariel K. M.
    Ng, Lui
    Li, Hung Sing
    Cheng, Chi Wai
    Lam, Colin S. C.
    Yau, Thomas C. C.
    Cheng, Paul N. M.
    Fan, Sheung Tat
    Poon, Ronnie T. P.
    Pang, Roberta W. C.
    [J]. CURRENT CANCER DRUG TARGETS, 2012, 12 (09) : 1233 - 1243
  • [2] SYNERGISTIC ANTI-TUMOR EFFICACY OF RECOMBINANT TUMOR NECROSIS FACTOR AND CHEMOTHERAPEUTIC-AGENTS INVIVO
    KROSNICK, JA
    MULE, JJ
    ROSENBERG, SA
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 432 - 432
  • [3] Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma
    Guichun Huang
    Longbang Chen
    [J]. Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1201 - 1211
  • [4] Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma
    Huang, Guichun
    Chen, Longbang
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (08) : 1201 - 1211
  • [5] Anti-tumor effect of vesnarinone on human hepatocellular carcinoma cell lines
    Kubo, K
    Matuzaki, Y
    Kato, A
    Terai, S
    Okita, K
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A1309 - A1309
  • [6] Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
    Cheng, Yang
    Luo, RongCheng
    Zheng, Hang
    Wang, Biao
    Liu, YaHui
    Liu, DingLi
    Chen, JinZhang
    Xu, WanFu
    Li, AiMin
    Zhu, Yun
    [J]. ONCOTARGET, 2017, 8 (14) : 23265 - 23276
  • [7] Anti-Tumor Effect of a Novel Soluble Recombinant Human Endostatin: Administered as a Single Agent or in Combination with Chemotherapy Agents in Mouse Tumor Models
    Ren, Zhihua
    Wang, Yanan
    Jiang, Wenhong
    Dai, Wei
    Jiang, Yongping
    [J]. PLOS ONE, 2014, 9 (09):
  • [8] Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest
    Lam, T. L.
    Wong, G. K. Y.
    Chong, H. C.
    Cheng, P. N. M.
    Choi, S. C.
    Chow, T. L.
    Kwok, S. Y.
    Poon, R. T. P.
    Wheatley, D. N.
    Lo, W. H.
    Leung, Y. C.
    [J]. CANCER LETTERS, 2009, 277 (01) : 91 - 100
  • [9] Anti-tumor efficacy of 0114 blockade in combination with sunitinib or aflibercept in primary human renal cell carcinoma models
    Miles, Kiersten Marie
    Gillard, Bryan
    Kuhnert, Frank
    Thurston, Gavin
    Lalani, Alshad S.
    Pili, Roberto
    [J]. CANCER RESEARCH, 2012, 72
  • [10] Anti-tumor in vivo efficacy of different classes of anti-CLEC-1 myeloid checkpoint antibodies in monotherapy and in combination with chemotherapeutic agents
    Morello, Aurore
    Derame, Mylene
    Drouin, Marion
    Wilhelm, Emmanuelle
    Neyton, Stephanie
    Baccelli, Irene
    Mary, Caroline
    Gauttier, Vanessa
    Girault, Isabelle
    Biteau, Kevin
    Batty, Cecile
    Teppaz, Geraldine
    Desselle, Ariane
    Colonello, Marion
    Malloci, Marine
    Chiffoleau, Elise
    Poirier, Nicolas
    [J]. CANCER RESEARCH, 2024, 84 (06)
12345